NPCE
Neuropace Inc
14.10$
+0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | -25.9% | -5.1% | +909.1% | -46.3% | +10.2% | +10.1% | |
| – | -4.4% | +210.9% | +94.7% | +14.5% | +7.6% | +7.8% | |
| – | -55.1% | +947.9% | +11.4% | – | – | – | |
| – | -23,066.7% | – | -1,401.1% | – | – | – | |
| – | -86.8% | +519.4% | +57.0% | -71.3% | +76.9% | +8.5% | |
| – | -397.6% | +693.1% | – | -3.2% | -60.9% | -103.7% | |
| – | – | – | -100.1% | +339.0% | -100.0% | – | |
| – | +14.7% | -116.7% | -100.0% | – | – | – | |
| – | +157.4% | +86.4% | -99.5% | +1,558.6% | -46.8% | +353.0% | |
| – | – | -132.9% | – | – | -140.4% | – | |
| – | – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.